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Excretion of 1-aminocyclopentanecarboxylic acid in man and the rat 
Recently we reported that  I-aminocyclopentanecarboxylic acid is almost completely 
reabsorbed by  the kidney of the rat, so that  only about 1% of that  present in the 
body is excreted in the urine per day 1. The present study shows first-order kinetics 
for its urinary excretion in man and the rat, with half-times of 3.5 and 22 days, 
respectively. In the latter species about two-thirds of the dose, unexpectedly, is 
excreted into the large intestine. The results show that  in both species a very adequate 
interval is available for the study of humoral or pathologic influences on the distri- 
bution and transport  of this model amino acid. 
Two men, ages 33 and 46, received in the deltoid muscle I and 2 mg, respectively 
(16. lO 6 and 32" lO s counts/min) of carboxyl-labeled I-aminocyclopentanecarboxylic 
acid s in aq. 0. 9 % NaC1. Urine was collected in daily portions, and blood plasma col- 
lected at the end of each 24-h interval, until the radioactivities became rather low 
for accurate counting. The plasma was treated with 0.075 vol. of aq. trichloroacetic 
acid (IOO g/Ioo ml). On removal of the precipitate the radioactivity of the filtrate 
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Fig. I. Decline in the  logari thm of p lasma level (round points) and of the daily ur inary-excret ion 
rate  (crosses) of injected i-aminoEi-z4C~cyclopentanecarboxylic acid in man.  
For the person shown in the upper curve, the plasma level and the urinary- 
excretion rates declined in good correspondence with first-order kinetics. The second 
subject showed a similar behavior after the first 2 days. The relationships between 
the plasma and urinary levels represent renal clearances of 6. 7 and 5.6 ml plasma 
per min. The two slopes correspond to half-times of 3.2 and 3.8 days. In the first 
3 days the first subject had excreted in the urine 47 % of the injected dose, in a 
week 76 % of the injected dose, in good agreement with the decay curves. The corre- 
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spondence was similar in the other case. Accordingly excretion by other routes in 
man must be less than the analytical error of not over 5 %. 
If we were to assume that  all of the amino acid present in each human subject 
was contained in a solution having the concentration found for the plasma, these 
solutions would have volumes of 48 and 56 1, respectively, values that  are very close 
to 60 % of the body weights of the subjects expressed in kilograms. Therefore we 
may  assume that  the amino acid is not concentrated into any tissue as abundant  
as muscle, and if it is concentrated into such organs as the liver, it must to a com- 
pensating degree be excluded from other portions of the body water. Greater overall 
accumulation occurs for a-aminoisobutyric acid into human tissues 3. In the mouse 
in the course of 6 h the present test amino acid was concentrated by 2-1o times into 
liver, and by 1.2 times into skeletal muscle 1. 
Male rats of about 15o g were injected subcutaneously in the scapular region 
with known amounts (6.6.1o 6 counts/rain, either 0.5 or lO.5 rag) of the test amino 
acid. The daily urine output was then collected in a metabolism cage at regular 
intervals for 91 days. The collecting surface was washed down with hot water at the 
end of each collection interval, and the radioactivity determined by  liquid scintil- 
lation counting, as described beforeL 
Fig. 2 shows the decline in the logarithm of daily urinary excretion in the male 
rat, representing a half-life of 22 days through a 9I-day interval. During this period, 
however, only one-third, rather than the predicted 94 % of the radioactivity had 
appeared in the urine. A similar discrepancy was seen in the mouse. Since volatile ~4C 
is not released into the environment of rats or mice receiving the labeled amino acidL 
the amino acid must either have been excreted by another route, or remain in the 
tissues. Analysis of liver and muscle showed that  the tissue radioactivity had declined 
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Fig. 2. Decl ine  in the  da i ly  u r ina ry -exc re t i on  r a t e  of t - a m i n o c y c l o p e n t a n e c a r b o x y l i c  acid in jec ted  
in to  rats .  The upper  circles, descr ib ing  the  uppe r  line, r ep resen t  the  ur ine  of two  ra t s  rece iv ing  
t o g e t h e r  i .o  mg  or I 3 . t '  IO e counts / ra in .  The smal l  po in t s  below th is  l ine r ep resen t  t he  resul t s  
w i t h  two  ra t s  rece iv ing  t o g e t h e r  21 mg  of 13. i .  lO 6 counts/min. The lower circles and  po in t s  h a v e  
the  s a m e  significance,  excep t  t h a t  t h e y  refer to s ingle an i ma l s  rece iv ing  s imi l a r  doses per  an i ma l .  
Biochim. Biophys..4eta, 62 (1962) 16o-162 
162 SHORT COMMUNICATIONS 
feces were examined for 14C, even though this route of excretion was insignificant for 
a-aminoisobutyric acid 4. The animals were picked up at hourly intervals and exposed 
to ether vapors to cause urination, so that  feces could be collected without contact 
with urine. The samples were extracted exhaustively with boiling water, and the ex- 
tracts centrifuged after adding a little conc. trichloroacetic acid. The extract was added 
in o.2-ml portions to the scintillator solution for counting as usual. During two 
8-h intervals on the third and fourth days after injection, fecal radioactivity in 2 rats 
represented the daily excretion of 1. 4 to 2.2 % (average, 1. 7 %) of the injected dose. 
This excretion rate was double the urinary rate and hence accounts adequately for 
the radioactivity not found in the urine. During the preparation of this report, a paper 
by STERLING et al. 5 appeared, reporting the predominance of the fecal route in the 
slow elimination of the amino acid by the rat. 
To determine the source of the fecal radioactivity we ligated the intestine in 
3 rats at the ileosecal junction, just before injecting the labeled amino acid sub- 
cutaneously. During the next 24 h the contents of the large intestihe came to contain 
0.6-0.8 % of the injected radioactivity; a very much lower content was found in the 
small intestine above the ligature. Accordingly much of the excretion appears to 
be performed by the large intestine. Rather little of the amino acid appeared in the 
bile, and ligation of the bile duct did not interfere with excretion by the intestinal 
route. Because the amino acid is absorbed vigorously by the small intestine 2 one 
would not expect secretion into the upper tract to contribute much to the loss from 
the animal. 
Renal tubular reabsorption of the test amino acid in the rat appeared to be 
nearly as complete at a dose of 7 ° mg as at a dose of 3.5 mg/kg body weight, since 
the excretion was only moderately accelerated at the higher dose (Fig. 2). Hence 
the agency mediating reabsorption was not yet saturated at this dosage. Transport 
of the amino acid probably occurs by a process serving for various neutral amino 
acids without distinguishing sharply among them. Therefore the effective load of 
amino acid handled by the renal process, as recorded by the tracer, was probably 
substantially larger than we might calculate for the test amino acid alone, and not 
greatly different at the two dosages. RIGGS AND WALKER 6 have shown that the dis- 
tribution of a-aminoisobutyric acid in the rat is virtually independent of the dose, 
until the dose is large enough to increase substantially the plasma total amino acid 
level. 
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